Recombinant Human YPEL2 Protein，GST

YPEL2, a member of the YPEL family of proteins, has garnered significant attention in recent years due to its involvement in various cellular processes and potential implications in human health and disease. Initially identified through genomic studies, YPEL2 has been linked to roles in cell proliferation, apoptosis, and differentiation. Research has indicated that it may act as a regulator of the cell cycle and is implicated in the modulation of oncogenic pathways, suggesting its potential as a tumor suppressor or promoter. Recent advances in molecular biology techniques have allowed for a more detailed characterization of YPEL2, revealing its interactions with multiple signaling pathways and cellular structures. Moreover, studies have highlighted its expression levels in various cancers, which further piques interest in its function and therapeutic potential. Understanding the structure and function of YPEL2 at a molecular level can provide insights into its biological roles and its contribution to disease mechanisms, paving the way for novel approaches in cancer treatment and other diseases where YPEL2 is implicated. Thus, ongoing research into YPEL2 aims to elucidate its precise functions and regulatory mechanisms, potentially positioning it as a biomarker or target for therapeutic strategies in oncology and other medical fields.